Drug Approval | November 22, 2023
Lupin receives approval from USFDA for Pitavastatin Tablets
Pitavastatin Tablets are indicated as an adjunct to diet to reduce low-density lipoprotein cholesterol
Pitavastatin Tablets are indicated as an adjunct to diet to reduce low-density lipoprotein cholesterol
Expanded collaboration with Vanguard Renewables aims to significantly increase the productivity of US renewable natural gas generation
Lack of technology transfer stands out as a formidable barrier
This product will be manufactured at Lupin’s Pithampur facility in India
The newly developed adhesive is available in two different grades. Loctite WT 3001 and Loctite WT 3003 h
Glenmark's current portfolio consists of 188 products authorized for distribution in the US
Tolvaptan Tablets (RLD Jynarque) had estimated annual sales of USD 287 million in the U.S. (IQVIA MAT August 2023)
The approval adds to a list of products that Strides has approved in this therapeutic category through the PEPFAR pathway taking the total to 15 products
Diofan Ultra736 provides ultra-high water vapor barrier with excellent thermoformability, unlocking the potential to design thinner and more sustainable blister films
Fillauer recently announced the launch of the first-ever bio-attributed prosthetic foot shell
Subscribe To Our Newsletter & Stay Updated
